COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?

The ongoing Corona virus (COVID-19) pandemic has witnessed global political responses of unimaginable proportions. Many nations have implemented lockdowns that involve mandating citizens not to leave their residences for non-essential work. The Indian government has taken appropriate and commendable steps to curtail the community spread of COVID-19. While this may be extremely beneficial, this perspective discusses the other reasons why COVID-19 may have a lesser impact on India. We analyze the current pattern of SARS-CoV-2 transmission, testing, and mortality in India with an emphasis on the importance of mortality as a marker of the clinical relevance of COVID-19 disease. We also analyze the environmental and biological factors which may lessen the impact of COVID-19 in India. The importance of cross-immunity, innate immune responses, ACE polymorphism, and viral genetic mutations are discussed.

[1]  J. Hindson.  COVID-19: faecal–oral transmission? , 2020, Nature Reviews Gastroenterology & Hepatology.

[2]  D. Gupta,et al.  Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis , 2020, bioRxiv.

[3]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[4]  Weifeng Lv,et al.  High Temperature and High Humidity Reduce the Transmission of COVID-19 , 2020, SSRN Electronic Journal.

[5]  C. Caruso,et al.  Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia , 2020, Aging and disease.

[6]  A. Shetty.  Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia , 2020, Aging and disease.

[7]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[8]  H. Rothan,et al.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.

[9]  A. S. St. John,et al.  Cross-Reactive Immunity Among Flaviviruses , 2020, Frontiers in Immunology.

[10]  Shengqing Wan,et al.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.

[11]  Marta Giovanetti,et al.  The first two cases of 2019‐nCoV in Italy: Where they come from? , 2020, Journal of medical virology.

[12]  Tiantian Han,et al.  Coronavirus infections and immune responses , 2020, Journal of medical virology.

[13]  J. E. Muñoz-Medina,et al.  Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population , 2019, Journal of immunology research.

[14]  S. Jadhav,et al.  Emerging/re-emerging viral diseases & new viruses on the Indian horizon , 2019, The Indian journal of medical research.

[15]  A. Berg,et al.  Present and future Köppen-Geiger climate classification maps at 1-km resolution , 2018, Scientific Data.

[16]  I. Gambhir,et al.  Morvan’s syndrome—is a pathogen behind the curtain? , 2018, Neurological Sciences.

[17]  Victor M Corman,et al.  Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study , 2015, The Lancet Infectious Diseases.

[18]  S. Perlman,et al.  Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.

[19]  Herman Tse,et al.  Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests , 2013, Journal of Infection.

[20]  K. Fink,et al.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology , 2012, Immunologic Research.

[21]  V. Cheng,et al.  Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome—Associated Coronavirus and Human Coronaviruses 229E and OC43 , 2005, The Journal of infectious diseases.

[22]  L. van der Hoek.  Human Coronaviruses: What Do They Cause? , 2005, Antiviral therapy.

[23]  I. Clark,et al.  Understanding the role of inflammatory cytokines in malaria and related diseases. , 2008, Travel medicine and infectious disease.